John B. Green, Senior VP and CFO at GTC BIOTHERAPEUTICS INC (GTCB), bought 1,500 shares at $0.89 ($1K) on 2007-12-14, disclosed to the SEC on 2007-12-14.
Open-market purchase of $1k GTCB by Senior VP and CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| DRNA | SELL | 2020-01-21 | $1.5M | — | Filing → |
| DRNA | SELL | 2019-11-27 | $312K | — | Filing → |
| DRNA | SELL | 2019-11-20 | $263K | — | Filing → |